European Foundation for the Study of Chronic Liver Failure, EFClif – Trademark Portfolio
Entity Type: 98
European Foundation for the Study of Chronic Liver Failure, EFClif holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes.
Travessera de Gràcia 11, 7º
E-08021 Barcelona
Showing of trademarks Trademarks
Trademark Classifications
European Foundation for the Study of Chronic Liver Failure, EFClif's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does European Foundation for the Study of Chronic Liver Failure, EFClif have?
European Foundation for the Study of Chronic Liver Failure, EFClif has 1 U.S. trademark filed with the USPTO.
What trademark classes does European Foundation for the Study of Chronic Liver Failure, EFClif file in?
European Foundation for the Study of Chronic Liver Failure, EFClif files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 16 (Paper Goods). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What is European Foundation for the Study of Chronic Liver Failure, EFClif's trademark registration success rate?
European Foundation for the Study of Chronic Liver Failure, EFClif has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.